[July 23, 2012] Exact Sciences Shares Up 34.2% Since SmarTrend's Buy Recommendation (EXAS) Tweet Jul 23, 2012 (SmarTrend(R) Spotlight via COMTEX) -- SmarTrend identified an Uptrend for Exact Sciences (NASDAQ:EXAS) on October 11th, 2011 at $7.72. In approximately 10 months, Exact Sciences has returned 34.20% as of today's recent price of $10.36. Exact Sciences share prices have moved between a 52-week high of $11.69 and a 52-week low of $5.08 and are now trading 104% above that low price at $10.36 per share. Over the last five market days, the 200-day moving average (MA) has gone up 1.2% while the 50-day MA has advanced 0.9%. EXACT Sciences Corporation is an applied genomics company that develops and commercializes proprietary DNA-based tests for the early detection of cancer. The Company's PreGen-Plus is intended for the early detection of colorectal cancer in the average-risk population. SmarTrend will continue to scan these moving averages and a number of other proprietary indicators for any shifts in the trajectory of Exact Sciences shares.Log in and add Exact Sciences (EXAS) to your watchlist today so you can receive a real-time alert when the shares are about to change trend. Write to Chip Brian at [email protected] --------------------------------------------------------------------------------------------- SmarTrend analyzes over 5,000 securities simultaneously throughout the trading day and provides its subscribers with trend change alerts in real time. To get a free trial of our trading calls and maximize your trading results, please visit http://www.MySmarTrend.com Get exclusive, actionable insight into how the market is expected to trend prior to market open with our free morning newsletter. Sign up at: http://www.MySmarTrend.com/signup [ Back To TMCnet.com's Homepage ]